Search

Displaying results 8541 - 8550 of 10000 in total
  1. Drug

    TSHA-118

    go.drugbank.com/drugs/DB16996
    Experimental

    TSHA-118 is a self-complementary AAV9 gene replacement therapy designed to express a human codon-optimized CLN1 transgene for the treatment of CLN1 disease.

  2. Drug

    ACT-101

    go.drugbank.com/drugs/DB17000
    Experimental

    ACT-101 is a recombinant human alpha-fetoprotein or rhAFP.

  3. Drug

    BB-301

    go.drugbank.com/drugs/DB17011
    Investigational

    BB-301 is a modified AAV serotype 9 (AAV9) capsid expressing a unique, single bifunctional construct promoting co-expression of both codon-optimized Poly-A Binding Protein Nuclear-1 (PABPN1) and two small

  4. Drug

    Indatraline

    go.drugbank.com/drugs/DB17032
    Experimental

    Indatraline is a nonselective monoamine reuptake inhibitor.[A253022]

  5. Drug

    Dacinostat

    go.drugbank.com/drugs/DB17034
    Experimental

    Dacinostat is a novel histone deacetylase inhibitor.[A253032]

  6. Drug

    PD-169316

    go.drugbank.com/drugs/DB17040
    Experimental

    PD-169316 is a p38 MAP kinase inhibitor.[A253062]

  7. Drug

    PD-173952

    go.drugbank.com/drugs/DB17041
    Experimental

    PD-173952 is a potent Myt1 kinase inhibitor.[A253067]

  8. Drug

    SB 224289

    go.drugbank.com/drugs/DB17052
    Experimental

    SB-224289 is a small molecule with a high affinity for human 5-HT1B receptors.[A253122]

  9. Drug

    Spiperone

    go.drugbank.com/drugs/DB17056
    Experimental

    Spiperone is a dopamine antagonist that binds dopamine and serotonin receptors.[A253142]

  10. Drug

    TW-37

    go.drugbank.com/drugs/DB17059
    Experimental

    TW-37 is a small-molecule inhibitor of Bcl-2 investigated for its anti-cancer properties.[A253157]